Analysts/Institutional Investor Meet/Con. Call Updates

Corporate Office: Solara Active Pharma Sciences Limited TICEL Bio Park, 6th Floor, Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113. Tel: +91 44 4344 6700 Fax: +91 44 47406190 E-mail: investors@solara.co.in Website: www.solara.co.in Date: July 16, 2026 The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Bandra-Kurla Dalal Street, Mumbai – 400 001 Complex, Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP1 Dear Sir / Madam, Subject: Intimation of Analysts / Investors Conference Call This is to inform you that the Company has scheduled a conference call with analysts/ investors to discuss Company’s unaudited financial results for the quarter ended June 30, 2026, as per the following details: Day and Date Time Meeting Type Scheduled for Thursday, July 23, 04:00 P.M (IST) Conference Call – Investors/ Analysts 2026 Group Meet Analysts / Investors Conference Call details are enclosed for ready reference. Further, kindly note that the above information will also be available on the website of the Company i.e., https://solara.co.in/investor-relations/schedule-of-investors-meet-and-investors-presentations/ This is for your kind information and records. Thanking you, Yours faithfully, For Solara Active Pharma Sciences Limited Pooja Jaya Kumar Company Secretary & Compliance Officer Membership No: A57415 Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 Registered Office: 9th Floor, ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703; Tel: +91-22-20870033 Solara Conference Call Thursday, 23rd July 2026, 4:00 pm IST Pure play APIs SOLARA ACTIVE PHARMA SCIENCES | Q1FY27 Sandeep Rao, MD & CEO Sarat Kumar, CFO Dial in Details: For Solara’s conference call, Thursday 23rd July 2026, 4:00 pm IST Universal Access +91 22 6280 1346 +91 22 7115 8247 Diamond Pass Click Here (for early registration)